Table 2.

Estimated hepatitis C virus seroprevalence and estimated number of seropositive individuals, 2013–2014, Belgium

Demographic characteristic		HCV seropositivity 2013–2014
		Number in study sample	Prevalence in Belgium		Individuals in Belgium
			%	95% CI	n	95% CI
Sex	Female	2	0.13	0.03–0.59	7200	1510–33,520
	Male	4	0.32	0.1–1.03	17,450	5370–56,380
Region	Brussels-Capital	2	1.05	0.35–3.15	12,180	4020–36,320
	Flanders	4	0.21	0.07–0.66	13,300	4180–42,180
	Wallonia	0	0	0–0.46	0	0–16,390
Age group (in years)	< 20	1	0.08	0.01–0.54	1990	290–13,700
	≥20	5	0.26	0.10–0.64	22,220	8890–55,420
	20–29	0	0	0–0.98	0	0–13,670
	30–39	1	0.31	0.04–2.27	4490	600–32,890
	40–49	1	0.13	0.02–1.14	2150	250–18,230
	50–59	2	0.74	0.16–3.41	11,240	2380–52,030
	60–69	1	0.44	0.06–3.34	5290	680–40,260
	70–79	0	0	0–4.51	0	0–36,840
	≥80	0	0	0–3.66	0	0–21,490
All		6	0.22	0.09–0.54	24,420	9990–59,940

Legend: HCV: hepatitis C virus, CI: confidence interval